Zhang Biao, Long Hong-Yan, Zhang Jin-Chun
Department of Pediatrics, Nanjing Municipal Hospital of Chinese Medicine, Nanjing.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Jul;32(7):926-9.
To study the effects of Jing'an Oral Liquid (JOL) on the central neurotransmitters of multiple tics (MT) children.
Sixty MT children patients were randomly assigned to the treatment group and the control group, 30 cases in each group. Another 30 healthy children were recruited as the health group. JOL and Tiapride Tablet (TT) was respectively given to patients in the treatment group and the control group. The treatment course was 2 months. The levels of central neurotransmitters [dopamine (DA), homovanillic acid (HVA), 5-hydroxytryptamine (5-HT), norepinephrine (NE), glutamic acid (GLU), aspartate (ASP), gamma-aminobutyric acid (GABA)] were measured using high performance liquid chromatography (HPLC) before and after treatment, and compared with the health group.
Compared with the health group, the levels of 5-HT, HVA, GLU, and ASP significantly increased in the treatment group and the control group before treatment (P < 0.05), GABA significantly decreased (P < 0.05). Compared with before treatment in the same group, the levels 5-HT, HVA, and GLU significantly decreased in the treatment group (P < 0.05), while the levels of NE and GABA significantly increased (P < 0.05). The levels of DA, 5-HT, GLU, and ASP significantly decreased, while the levels of NE ang GABA significantly increased in the control group, showing statistical difference (P < 0.05). There was no statistical difference in each index between the treatment group and the control group before and after treatment (P > 0.05).
(1) The imbalance of a variety of monoamines and amino acid neurotransmitters can lead to MT, especially in the changes of 5-HT, HVA, GLU, ASP, and GABA. (2) JOL can significantly reduce the levels of 5-HT, HVA, and GLU, and significantly increase the levels of NE and GABA, which might be its pharmacodynamic mechanisms for treating MT.
研究静安口服液(JOL)对多发性抽动症(MT)患儿中枢神经递质的影响。
将60例MT患儿随机分为治疗组和对照组,每组30例。另招募30例健康儿童作为健康组。治疗组和对照组患儿分别给予JOL和硫必利片(TT)。疗程为2个月。采用高效液相色谱法(HPLC)测定治疗前后中枢神经递质[多巴胺(DA)、高香草酸(HVA)、5-羟色胺(5-HT)、去甲肾上腺素(NE)、谷氨酸(GLU)、天冬氨酸(ASP)、γ-氨基丁酸(GABA)]水平,并与健康组进行比较。
与健康组相比,治疗组和对照组治疗前5-HT、HVA、GLU和ASP水平显著升高(P<0.05),GABA显著降低(P<0.05)。与同组治疗前相比,治疗组5-HT、HVA和GLU水平显著降低(P<0.05),而NE和GABA水平显著升高(P<0.05)。对照组DA、5-HT、GLU和ASP水平显著降低,而NE和GABA水平显著升高,差异有统计学意义(P<0.05)。治疗组与对照组治疗前后各指标比较,差异无统计学意义(P>0.05)。
(1)多种单胺类和氨基酸类神经递质失衡可导致MT,尤其是5-HT、HVA、GLU、ASP和GABA的变化。(2)JOL可显著降低5-HT、HVA和GLU水平,显著升高NE和GABA水平,这可能是其治疗MT的药效学机制。